THURSDAY, June 10, 2021 (HealthDay News) — When antidepressants fail to rein in hard-to-treat depression, the common anesthetic most know as “laughing gas” might be a safe and effective alternative, new research suggests. The finding follows work with 28 patients struggling with “treatment-resistant major depression,” a severe condition that investigatorsContinue Reading

THURSDAY, June 10, 2021 (HealthDay News) — The color of your skin may very well determine how your headache gets treated, a new study warns. The same percentage of white, Black and Hispanic Americans — about 15% — suffer from severe headaches and/or migraines, the investigators noted. But the currentContinue Reading

THURSDAY, June 10, 2021 (HealthDay News) — The coronavirus pandemic has affected American smokers in different ways, a new study finds. While some smoked more to help them cope with the crisis, others quit to reduce their COVID-19 infection risk. “Even before the pandemic, tobacco smoking was the leading preventableContinue Reading

MONDAY, June 7, 2021 (HealthDay News) — People hospitalized for COVID-19 are often discharged in much worse shape than before their illness — underscoring the value of preventing severe cases with vaccination. In a new study, researchers found that during the pandemic’s early months, almost half of COVID-19 patients dischargedContinue Reading

FRIDAY, June 4, 2021 (HealthDay News) — A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as aContinue Reading

FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP that normally fixes DNA damage inContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — As a means of providing long-term relief from chronic pain, flotation tanks simply don’t hold water, new research reveals. Nearly 100 people plagued by longstanding pain underwent “flotation restricted environmental stimulation therapy” (REST), and the results were disappointing, at least over the longContinue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — People with spinal cord injuries can overwork their shoulders as they move about in a wheelchair, and that often leads to chronic shoulder pain. However, a small study suggests that an injection of the patient’s own fat cells can help ease the pain.Continue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — Moderate use of hair relaxers doesn’t increase a Black woman’s risk of breast cancer, according to a new study. “While there is biologic plausibility that exposure to some components contained in hair relaxers might increase breast cancer risk, the evidence from epidemiologic studiesContinue Reading